Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy

NCT02069847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Stricture

Interventions

DRUG: Budesonide

Sponsor

Mayo Clinic